Key result
Diuretics and ACE inhibitors remain first-line for pediatric heart failure before end-stage transplant or VADs.
Why the study?
There is a lack of an equivalent consensus or well-established guidelines for the management of heart failure in children compared to adults.
Population
Children with heart failure
Design
Review
Authors
Loading...
Novel pediatric HF data; leaves open optimal therapy selection pending randomized trials.
This review provides a practical guide to the diagnosis and management of pediatric heart failure, highlighting the use of diuretics, ACE inhibitors, and advanced therapies like LVADs and transplantation.
Masarone et al. (2017) conducted a review in Pediatric heart failure. Pediatric heart failure management relies on diuretics and ACE inhibitors as first-line therapies, with heart transplantation or ventricular assist devices reserved for end-stage disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: